يعرض 1 - 10 نتائج من 95 نتيجة بحث عن '"Gibbs, Simon D."', وقت الاستعلام: 1.10s تنقيح النتائج
  1. 1
    دورية أكاديمية
  2. 2
    دورية أكاديمية
  3. 3
    دورية أكاديمية
  4. 4
    دورية أكاديمية
  5. 5
    مؤتمر

    جغرافية الموضوع: Atlanta, USA

    الوقت: 2021-12-11 to 2021-12-14

    العلاقة: Blood; 63rd ASH Annual Meeting Abstracts: Poster Abstracts; 63rd ASH Annual Meeting; Mollee, P; Reynolds, J; Janowski, W; Quach, H; Campbell, P; Gibbs, SD; Lee, S; D'Rozario, J; Taylor, K; Cochrane, T; Wallington-Beddoe, CT; Kwok, F; Weber, N; Kerridge, IH; Weston, H; et al., A Randomized Study of Bortezomib, Cyclophosphamide and Dexamethasone Induction (VCD) Versus VCD and Daratumumab Induction Followed By Daratumumab Maintenance (VCDD) for the Initial Treatment of Transplant-Ineligible Patients with Multiple Myeloma (AMaRC 03-16), Blood, 2021, 138 (Supplement 1), pp. 2728-2729; http://hdl.handle.net/10072/424564Test

  6. 6
    دورية أكاديمية

    المصدر: Bahlis , N J , Baz , R , Harrison , S J , Quach , H , Ho , S J , Vangsted , A J , Plesner , T , Moreau , P , Gibbs , S D , Coppola , S , Yang , X , Al Masud , A , Ross , J A , Bueno , O & Kaufman , J L 2021 , ' Phase I Study of Venetoclax Plus Daratumumab and Dexamethasone, With or Without Bortezomib, in Patients With Relapsed or Refractory Multiple Myeloma With and Without t(11;14) ' , Journal of ....

    وصف الملف: application/pdf

  7. 7
  8. 8
    دورية أكاديمية
  9. 9
    مؤتمر

    المصدر: Bahlis , N J , Kaufman , J L , Baz , R , Quach , H , Ho , S-J , Vangsted , A J , Plesner , T , Moreau , P , Gibbs , S D , Medvedova , E , Bueno , O F , Luo , Y , Mantis , C , Vishwamitra , D , Ross , J A & Harrison , S J 2021 , ' Rapid and Sustained Reduction of Immunosuppressive T-Cells and Focusing of the T-Cell Repertoire in t(11;14) Relapsed/Refractory Multiple Myeloma Patients Treated with Venetoclax in Combination with Daratumumab ....

  10. 10
    مؤتمر

    المصدر: Kaufman , J L , Quach , H , Baz , R , Vangsted , A J , Ho , S-J , Harrison , S J , Plesner , T , Moreau , P , Gibbs , S D , Medvedova , E , Sehgal , V , Kang , K , Ross , J A , Lash-Fleming , L L , Luo , Y & Bahlis , N J 2021 , ' Safety and Preliminary Efficacy from the Expansion Cohort of a Phase 1/2 Study of Venetoclax Plus Daratumumab and Dexamethasone Vs Daratumumab Plus Bortezomib and Dexamethasone in ....